Magnetic resonance imaging to detect early molecular and cellular changes in Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 8, Issue JUN, 2016, Pages

  Knight, Michael J ^a   McCann, Bryony ^a   Kauppinen, Risto A ^a   Coulthard, Elizabeth J ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NORTH BRISTOL NHS TRUST   (United Kingdom)

Author keywords

Alzheimer's; Diffusion tensor imaging; Magnetic resonance imaging; Relaxometry; Shape analysis

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN PERFUSION; BRAIN TISSUE; COGNITIVE DEFECT; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFUSION TENSOR IMAGING; DISEASE COURSE; EARLY DIAGNOSIS; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LUMBAR PUNCTURE; MORPHOMETRICS; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; SENSITIVITY ANALYSIS; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY;

EID: 84980368744     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2016.00139     Document Type: Short Survey

References (108)

1. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270-279. doi: 10.1016/j.jalz.2011.03.008.
2. Alsop, D. C., Dai, W., Grossman, M., and Detre, J. A. (2010). Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J. Alzheimers Dis. 20, 871-880. doi: 10.3233/JAD-2010-091699.
3. Alsop, D. C., Detre, J. A., Golay, X., Gunther, M., Hendrikse, J., Hernandez-Garcia, L., et al. (2015). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Mag. Reson. Med. 73, 102-116. doi: 10.1002/mrm.25197.
4. Amlien, I. K., and Fjell, A. M. (2014). Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment. Neuroscience 276, 206-215. doi: 10.1016/j.neuroscience.2014.02.017.
5. Archer, H. A., Smailagic, N., John, C., Holmes, R. B., Takwoingi, Y., Coulthard, E. J., et al. (2015). Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia. Cochrane Database of Syst. Rev, CD010896. doi: 10.1002/14651858.CD010896.pub2.
6. Barazany, D., and Assaf, Y. (2012). Visualization of cortical lamination patterns with magnetic resonance imaging. Cereb. Cortex 22, 2016-2023. doi: 10.1093/cercor/bhr277.
7. Basser, P. J., and Jones, D. K. (2002). Diffusion-tensor MRI: theory, experimental design and data analysis-a technical review. NMR Biomed. 15, 456-467. doi: 10.1002/nbm.783.
8. Bendlin, B. B., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., Willette, A. A., et al. (2012). CSF T-Tau/Abeta42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS ONE 7:e37720. doi: 10.1371/journal.pone.0037720.
9. Binnewijzend, M. A., Kuijer, J. P., van der Flier, W. M., Benedictus, M. R., Moller, C. M., Pijnenburg, Y. A., et al. (2014). Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies. Eur. Radiol. 24, 2326-2333. doi: 10.1007/s00330-014-3172-3.
10. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer's related-changes. Acta Neuropathol. 82, 239-259. doi: 10.1007/BF00308809.
11. Callaghan, M. F., Freund, P., Draganski, B., Anderson, E., Cappelletti, M., Chowdhury, R., et al. (2014). Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol. Aging 35, 1862-1872. doi: 10.1016/j.neurobiolaging.2014.02.008.
12. Ceyhan, E., Beg, M. F., Cerito, C., Wang, L., Morris, J. C., Csernansky, J. G., et al. (2011). Quantization and analysis of hippocampal morphometric changes due to dementia of Alzheimer type using metric distances based on large deformation diffeomorphic metric mapping. Comput. Med. Imaging Graph. 35, 275-293. doi: 10.1016/j.compmedimag.2011.01.005.
13. Chan, D., Fox, N. C., Scahill, R. I., Crum, W. R., Whitwell, J. L., Leschziner, G., et al. (2001). Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann. Neurol. 49, 433-442. doi: 10.1002/ana.92.
14. Chiang, G. C., Insel, P. S., Tosun, D., Schuff, N., Truran-Sacrey, D., Raptentsetsang, S., et al. (2011). Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology 259, 844-851. doi: 10.1148/radiol.11101637.
15. Clerx, L., Visser, P. J., Verhey, F., and Aalten, P. (2012). New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements. J. Alzheimers Dis. 29, 405-429. doi: 10.3233/JAD-2011-110797.
16. Costafreda, S. G., Dinov, I. D., Tu, Z., Shi, Y., Liu, C.-Y., Kloszewska, I., et al. (2011). Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage 56, 212-219. doi: 10.1016/j.neuroimage.2011.01.050.
17. Dale, A. M., Fischl, B., and Sereno, M. I. (1999). Cortical surface-based analysis: Segmentation, I., and surface reconstruction. Neuroimage 9, 179-194. doi: 10.1006/nimg.1998.0395.
18. de Flores, R., La Joie, R., and Chetelat, G. (2015). Structural imaging of hippocampal subfields in healthy aging and Alzheimer's disease. Neuroscience. 309, 29-50. doi: 10.1016/j.neuroscience.2015.08.033.
19. de la Torre J. C. (2000). Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease? Ann. N.Y. Acad. Sci. 903, 424-436. doi: 10.1111/j.1749-6632.2000.tb06394.x.
20. Devanand, D., Pradhaban, G., Liu, X., Khandji, A., De Santi, S., Segal, S., et al. (2007). Hippocampal and entorhinal atrophy in mild cognitive impairment Prediction of Alzheimer disease. Neurology 68, 828-836. doi: 10.1212/01.wnl.0000256697.20968.d7.
21. Douaud, G., Menke, R. A., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., et al. (2013). Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease. J. Neurosci. 33, 2147-2155. doi: 10.1523/JNEUROSCI.4437-12.2013.
22. Du, A.-T., Schuff, N., Kramer, J. H., Rosen, H. J., Gorno-Tempini, M. L., Rankin, K., et al. (2007). Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130, 1159-1166. doi: 10.1093/brain/awm016.
23. Duvernoy, H. M. (2005). The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI. Berlin; Heidelberg: Springer-Verlag.
24. Ellis, R. J., Olichney, J. M., Thal, L. J., Mirra, S. S., Morris, J. C., Beekly, D., et al. (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 46, 1592-1596. doi: 10.1212/WNL.46.6.1592.
25. Ewers, M., Walsh, C., Trojanowski, J. Q., Shaw, L. M., Petersen, R. C., Jack, C. R., et al. (2012). Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol. Aging 33, 1203-1214. doi: 10.1016/j.neurobiolaging.2010.10.019.
26. Fearing, M. A., Bigler, E. D., Norton, M., Tschanz, J. A., Hulette, C., Leslie, C., et al. (2007). Autopsy-confirmed Alzheimer's disease versus clinically diagnosed Alzheimer's disease in the Cache County Study on Memory and Aging: a comparison of quantitative MRI and neuropsychological findings. J. Clin. Exp. Neuropsychol. 29, 553-560. doi: 10.1080/13803390600826579.
27. Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Ségonne, F., Salat, D. H., et al. (2004). Automatically parcellating the human cerebral cortex. Cereb. Cortex 14, 11-22. doi: 10.1093/cercor/bhg087.
28. Fjell, A. M., Sneve, M. H., Storsve, A. B., Grydeland, H., Yendiki, A., and Walhovd, K. B. (2015). Brain events underlying episodic memory changes in aging: a longitudinal investigation of structural and functional connectivity. Cereb. Cortex. 1-15. doi: 10.1093/cercor/bhv102.
29. Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N., Friston, K. J., and Frackowiak, R. S. (2001). A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14, 21-36. doi: 10.1006/nimg.2001.0786.
30. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., and Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 5, 228-234. doi: 10.1016/S1474-4422(06)70355-6.
31. Haris, M., Singh, A., Cai, K., McArdle, E., Fenty, M., Davatzikos, C., et al. (2011). T(1rho) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe. J. Neuroimaging 21, e86-e90. doi: 10.1111/j.1552-6569.2010.00467.x.
32. Haris, M., Yadav, S. K., Rizwan, A., Singh, A., Cai, K., Kaura, D., et al. (2015). T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease. Neuroimage Clin. 7, 598-604. doi: 10.1016/j.nicl.2015.02.016.
33. Heckemann, R. A., Keihaninejad, S., Aljabar, P., Gray, K. R., Nielsen, C., Rueckert, D., et al. (2011). Automatic morphometry in Alzheimer's disease and mild cognitive impairment. Neuroimage 56, 2024-2037. doi: 10.1016/j.neuroimage.2011.03.014.
34. Holland, D., Desikan, R. S., Dale, A. M., McEvoy, L. K., and Alzheimer's Disease Neuroimaging Initiative (2012). Rates of decline in Alzheimer disease decrease with age. PLoS ONE 7:e42325. doi: 10.1371/journal.pone.0042325.
35. Hong, Y. J., Yoon, B., Lim, S. C., Shim, Y. S., Kim, J. Y., Ahn, K. J., et al. (2013). Microstructural changes in the hippocampus and posterior cingulate in mild cognitive impairment and Alzheimer's disease: a diffusion tensor imaging study. Neurol. Sci. 34, 1215-1221. doi: 10.1007/s10072-012-1225-4.
36. Jack, C., Dickson, D. W., Parisi, J. E., Xu, Y., Cha, R., O'brien, P., et al. (2002). Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58, 750-757. doi: 10.1212/WNL.58.5.750.
37. Jack, C. R. Jr. (2012). Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 263, 344-361. doi: 10.1148/radiol.12110433.
38. Jack, C. R., Barnes, J., Bernstein, M. A., Borowski, B. J., Brewer, J., Clegg, S., et al. (2015). Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2. Alzheimer's Dement. 11, 740-756. doi: 10.1016/j.jalz.2015.05.002.
39. Jack, C. R. Jr., Knopman, D. S., Chetelat, G., Dickson, D., Fagan, A. M., Frisoni, G. B., et al. (2016). Suspected non-Alzheimer disease pathophysiology [mdash] concept and controversy. Nat. Rev. Neurol. 12, 117-124. doi: 10.1038/nrneurol.2015.251.
40. Jack, C. R. Jr., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P.S., et al. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207-216. doi: 10.1016/S1474-4422(12)70291-0.
41. Jack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., et al. (2012). An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann. Neurol. 71, 765-775. doi: 10.1002/ana.22628.
42. Jacobs, H. I., van Boxtel, M. P., Gronenschild, E. H., Uylings, H. B., Jolles, J., and Verhey, F. R. (2013). Decreased gray matter diffusivity: a potential early Alzheimer's disease biomarker? Alzheimers Dement. 9, 93-97. doi: 10.1016/j.jalz.2011.11.004.
43. Jorm, A. F., and Jolley, D. (1998). The incidence of dementia: a meta-analysis. Neurology 51, 728-733. doi: 10.1212/WNL.51.3.728.
44. Kantarci, K. (2013). Proton MRS in mild cognitive impairment. J. Magn. Reson. Imaging 37, 770-777. doi: 10.1002/jmri.23800.
45. Kapogiannis, D., and Mattson, M. P. (2011). Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10, 187-198. doi: 10.1016/S1474-4422(10)70277-5.
46. Krajcovicova, L., Marecek, R., Mikl, M., and Rektorova, I. (2014). Disruption of resting functional connectivity in Alzheimer's patients and at-risk subjects. Curr. Neurol. Neurosci. Rep. 14, 491. doi: 10.1007/s11910-014-0491-3.
47. La Joie, R., Perrotin, A., De La Sayette, V., Egret, S., Doeuvre, L., Belliard, S., et al. (2013). Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer's disease and semantic dementia. Neuroimage Clin. 3, 155-162. doi: 10.1016/j.nicl.2013.08.007.
48. Landau, S., Harvey, D., Madison, C., Reiman, E., Foster, N., Aisen, P., et al. (2010). Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75, 230-238. doi: 10.1212/WNL.0b013e3181e8e8b8.
49. Lehmann, M., Koedam, E. L., Barnes, J., Bartlett, J. W., Barkhof, F., Wattjes, M. P., et al. (2013). Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiol. Aging 34, 73-82. doi: 10.1016/j.neurobiolaging.2012.03.010.
50. Leung, K. K., Bartlett, J. W., Barnes, J., Manning, E. N., Ourselin, S., and Fox, N. C. (2013). Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 80, 648-654. doi: 10.1212/WNL.0b013e318281ccd3.
51. Li, Q., Pardoe, H., Lichter, R., Werden, E., Raffelt, A., Cumming, T., et al. (2015). Cortical thickness estimation in longitudinal stroke studies: a comparison of 3 measurement methods. Neuroimage Clin. 8, 526-535. doi: 10.1016/j.nicl.2014.08.017.
52. Li, X., Jiao, J., Shimizu, S., Jibiki, I., Watanabe, K., and Kubota, T. (2012). Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment. Psychiatry Clin. Neurosci. 66, 587-593. doi: 10.1111/pcn.12002.
53. Li, Y. D., Dong, H. B., Xie, G. M., and Zhang, L. J. (2013). Discriminative analysis of mild Alzheimer's disease and normal aging using volume of hippocampal subfields and hippocampal mean diffusivity: an in vivo magnetic resonance imaging study. Am. J. Alzheimers Dis. Other Demen. 28, 627-633. doi: 10.1177/1533317513494452.
54. Liu, X., Tosun, D., Weiner, M. W., Schuff, N., and Alzheimer's Disease Neuroimaging Initiative (2013). Locally linear embedding (LLE) for MRI based Alzheimer's disease classification. Neuroimage 83, 148-157. doi: 10.1016/j.neuroimage.2013.06.033.
55. Liu-Seifert, H., Siemers, E., Holdridge, K. C., Andersen, S. W., Lipkovich, I., Carlson, C., et al. (2015). Delayed-start analysis: mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimers Dement. 1, 111-121. doi: 10.1016/j.trci.2015.06.006.
56. MacKay, A., Whittall, K., Adler, J., Li, D., Paty, D., and Graeb, D. (1994). In vivo visualization of myelin water in brain by magnetic resonance. Mag. Reson. Med. 31, 673-677. doi: 10.1002/mrm.1910310614.
57. Madden, D. J., Bennett, I. J., Burzynska, A., Potter, G. G., Chen, N. K., and Song, A. W. (2012). Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. Biochim. Biophys. Acta 1822, 386-400. doi: 10.1016/j.bbadis.2011.08.003.
58. Marshall, G. A., Lorius, N., Locascio, J. J., Hyman, B. T., Rentz, D. M., Johnson, K. A., et al. (2014). Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's Disease spectrum. J. Alzheimers Dis. 41, 719-728. doi: 10.3233/JAD-132768.
59. Maruszak, A., and Thuret, S. (2014). Why looking at the whole hippocampus is not enough-a critical role for anteroposterior axis, subfield and activation analyses to enhance predictive value of hippocampal changes for Alzheimer's disease diagnosis. Front. Cell. Neurosci. 8:95. doi: 10.3389/fncel.2014.00095.
60. Mazza, M., Marano, G., Traversi, G., Bria, P., and Mazza, S. (2011). Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J. Alzheimers Dis. 23, 375-389. doi: 10.3233/JAD-2010-090700.
61. McMillan, C. T., Avants, B. B., Cook, P., Ungar, L., Trojanowski, J. Q., and Grossman, M. (2014). The power of neuroimaging biomarkers for screening frontotemporal dementia. Hum. Brain Mapp. 35, 4827-4840. doi: 10.1002/hbm.22515.
62. Murray, M. E., Przybelski, S. A., Lesnick, T. G., Liesinger, A. M., Spychalla, A., Zhang, B., et al. (2014). Early Alzheimer's disease neuropathology detected by proton MR spectroscopy. J. Neurosci. 34, 16247-16255. doi: 10.1523/JNEUROSCI.2027-14.2014.
63. Musiek, E. S., Chen, Y., Korczykowski, M., Saboury, B., Martinez, P. M., Reddin, J. S., et al. (2012). Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement. 8, 51-59. doi: 10.1016/j.jalz.2011.06.003.
64. Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., et al. (2013). Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin. 3, 180-195. doi: 10.1016/j.nicl.2013.07.006.
65. O'Brien, J. T., Firbank, M. J., Davison, C., Barnett, N., Bamford, C., Donaldson, C., et al. (2014). 18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias. J. Nucl. Med. 55, 1959-1965. doi: 10.2967/jnumed.114.143347.
66. Oz, G., Alger, J. R., Barker, P. B., Bartha, R., Bizzi, A., Boesch, C., et al. (2014). Clinical proton MR spectroscopy in central nervous system disorders. Radiology 270, 658-679. doi: 10.1148/radiol.13130531.
67. Palesi, F., Vitali, P., Chiarati, P., Castellazzi, G., Caverzasi, E., Pichiecchio, A., et al. (2012). DTI and MR Volumetry of Hippocampus-PC/PCC Circuit: in search of early micro-and macrostructural signs of Alzheimers's Disease. Neurol Res. Int. 2012:517876. doi: 10.1155/2012/517876.
68. Perl, D. P. (2010). Neuropathology of Alzheimer's disease. Mt. Sinai J. Med. 77, 32-42. doi: 10.1002/msj.20157.
69. Perrotin, A., de Flores, R., Lamberton, F., Poisnel, G., La Joie, R., de la Sayette, V., et al. (2015). Hippocampal subfield volumetry and 3D surface mapping in subjective cognitive decline. J. Alzheimers Dis. 48(Suppl. 1), S141-S150. doi: 10.3233/jad-150087.
70. Peters, R. (2006). Ageing and the brain. Postgrad. Med. J. 82, 84-88. doi: 10.1136/pgmj.2005.036665.
71. Redolfi, A., Manset, D., Barkhof, F., Wahlund, L.-O., Glatard, T., Mangin, J.-F, et al. (2015). Head-to-head comparison of two popular cortical thickness extraction algorithms: a cross-sectional and longitudinal study. PLoS One 10:e0117692. doi: 10.1371/journal.pone.0117692.
72. Risacher, S. L., Saykin, A. J., West, J. D., Shen, L., Firpi, H. A., and McDonald, B. C. (2009). Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr. Alzheimer Res. 6, 347-361. doi: 10.2174/156720509788929273.
73. Salat, D. H., Chen, J. J., van der Kouwe, A. J., Greve, D. N., Fischl, B., and Rosas, H. D. (2011). Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage 54, 1795-1802. doi: 10.1016/j.neuroimage.2010.10.034.
74. Salat, D. H., Kaye, J. A., and Janowsky, J. S. (1999). Prefrontal gray and white matter volumes in healthy aging and Alzheimer disease. Arch. Neurol. 56, 338-344. doi: 10.1001/archneur.56.3.338.
75. Santillo, A. F., Mårtensson, J., Lindberg, O., Nilsson, M., Manzouri, A., Landqvist Waldö, M., et al. (2013). Diffusion tensor tractography versus volumetric imaging in the diagnosis of behavioral variant frontotemporal dementia. PLoS ONE 8:e66932. doi: 10.1371/journal.pone.0066932.
76. Scahill, R. I., and Fox, N. C. (2007). Longitudinal imaging in dementia. Br. J. Radiol. 80, S92-S98. doi: 10.1259/bjr/78981552.
77. Schöll, M., Samuel Lockhart, N., Daniel Schonhaut, R., James O'Neil, P., Janabi, M., Ossenkoppele, R., et al. (2016). PET imaging of Tau Deposition in the aging human brain. Neuron 89, 971-982. doi: 10.1016/j.neuron.2016.01.028.
78. Schuff, N., Tosun, D., Insel, P. S., Chiang, G. C., Truran, D., Aisen, P. S., et al. (2012). Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol. Aging 33, 845-855. doi: 10.1016/j.neurobiolaging.2010.07.012.
79. Schuff, N., Woerner, N., Boreta, L., Kornfield, T., Shaw, L. M., Trojanowski, J. Q., et al. (2009). MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 132, 1067-1077. doi: 10.1093/brain/awp007.
80. Selnes, P., Aarsland, D., Bjornerud, A., Gjerstad, L., Wallin, A., Hessen, E., et al. (2013). Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment. J. Alzheimers Dis. 33, 723-736. doi: 10.3233/JAD-2012-121603.
81. Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., and Ebmeier, K. P. (2011). A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 32, 2322.e5-18. doi: 10.1016/j.neurobiolaging.2010.05.019.
82. Sheline, Y. I., and Raichle, M. E. (2013). Resting state functional connectivity in preclinical Alzheimer's disease. Biol. Psychiatry 74, 340-347. doi: 10.1016/j.biopsych.2012.11.028.
83. Shu, N., Wang, Z., Qi, Z., Li, K., and He, Y. (2011). Multiple diffusion indices reveals white matter degeneration in Alzheimer's disease and mild cognitive impairment: a tract-based spatial statistics study. J. Alzheimers Dis. 26(Suppl. 3), 275-285. doi: 10.3233/JAD-2011-0024.
84. Silbert, L., Quinn, J., Moore, M., Corbridge, E., Ball, M., Murdoch, G., et al. (2003). Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology 61, 487-492. doi: 10.1212/01.WNL.0000079053.77227.14.
85. Small, G. W., Kepe, V., Ercoli, L. M., Siddarth, P., Bookheimer, S. Y., Miller, K. J., et al. (2006). PET of brain amyloid and Tau in mild cognitive impairment. N. Engl. J. Med. 355, 2652-2663. doi: 10.1056/NEJMoa054625.
86. Sotiropoulos, S. N., Jbabdi, S., Xu, J., Andersson, J. L., Moeller, S., Auerbach, E. J., et al. (2013). Advances in diffusion MRI acquisition and processing in the Human Connectome Project. Neuroimage 80, 125-143. doi: 10.1016/j.neuroimage.2013.05.057.
87. Sperling, R. A., Jack, C. R. Jr., Black, S. E., Frosch, M. P., Greenberg, S. M., Hyman, B. T., et al. (2011). Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement. 7, 367-385. doi: 10.1016/j.jalz.2011.05.2351.
88. Stebbins, G. T., and Murphy, C. M. (2009). Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav. Neurol. 21, 39-49. doi: 10.1155/2009/915041.
89. Sullivan, E. V., Marsh, L., Mathalon, D. H., Lim, K. O., and Pfefferbaum, A. (1995). Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol. Aging 16, 591-606. doi: 10.1016/0197-4580(95)00074-O.
90. Thompson, P. M., Hayashi, K. M., de Zubicaray, G. I., Janke, A. L., Rose, S. E., Semple, J., et al. (2004). Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 22, 1754-1766. doi: 10.1016/j.neuroimage.2004.03.040.
91. Tumati, S., Martens, S., and Aleman, A. (2013). Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis. Neurosci. Biobehav. Rev. 37, 2571-2586. doi: 10.1016/j.neubiorev.2013.08.004.
92. Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., et al. (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273-289. doi: 10.1006/nimg.2001.0978.
93. Van Hoesen, G. W., Hyman, B. T., and Damasio, A. R. (1991). Entorhinal cortex pathology in Alzheimer's disease. Hippocampus 1, 1-8. doi: 10.1002/hipo.450010102.
94. Vandenberghe, R., Adamczuk, K., Dupont, P., Laere, K. V., and Chételat, G. (2013). Amyloid PET in clinical practice: its place in the multidimensional space of Alzheimer's disease. Neuroimage Clin. 2, 497-511. doi: 10.1016/j.nicl.2013.03.014.
95. Wang, H., Tan, L., Wang, H. F., Liu, Y., Yin, R. H., Wang, W. Y., et al. (2015). Magnetic resonance spectroscopy in Alzheimer's Disease: systematic review and meta-analysis. J. Alzheimers Dis. 46, 1049-1070. doi: 10.3233/JAD-143225.
96. Wang, L., Swank, J. S., Glick, I. E., Gado, M. H., Miller, M. I., Morris, J. C., et al. (2003). Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage 20, 667-682. doi: 10.1016/S1053-8119(03)00361-6.
97. Ward, A., Tardiff, S., Dye, C., and Arrighi, H. M. (2013). Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dement. Geriatr. Cogn. Dis. Extra 3, 320-332. doi: 10.1159/000354370.
98. Weiner, M. W., Veitch, D. P., Aisen, P. S., Beckett, L. A., Cairns, N. J., Cedarbaum, J., et al. (2015). 2014 Update of the Alzheimer's Disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 11, e1-e120. doi: 10.1016/j.jalz.2014.11.001.
99. Westlye, L. T., Walhovd, K. B., Dale, A. M., Espeseth, T., Reinvang, I., Raz, N., et al. (2009). Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: a multi-sample MRI study. Neuroimage 47, 1545-1557. doi: 10.1016/j.neuroimage.2009.05.084.
100. Whitwell, J. L., Dickson, D. W., Murray, M. E., Weigand, S. D., Tosakulwong, N., Senjem, M. L., et al. (2012). Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol. 11, 868-877. doi: 10.1016/S1474-4422(12)70200-4.
101. Wierenga, C. E., Hays, C. C., and Zlatar, Z. Z. (2014). Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease. J. Alzheimers Dis. 42(Suppl. 4), S411-S419. doi: 10.3233/JAD-141467.
102. Wolk, D. A., and Detre, J. A. (2012). Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr. Opin. Neurol. 25, 421-428. doi: 10.1097/WCO.0b013e328354ff0a.
103. Wood, B., Knight, M. J., Tsivos, D., Oliver, R., Coulthard, E., and Kauppinen, R. A. (2015). Magnetic resonance scanning and image segmentation procedure at 3 T for volumetry of human hippocampal subfields. Biomed. Spectrosc. Imaging 4, 197-208. doi: 10.3233/BSI-150109.
104. Yang, J., Pan, P., Song, W., Huang, R., Li, J., Chen, K., et al. (2012). Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation. J. Neurol. Sci. 316, 21-29. doi: 10.1016/j.jns.2012.02.010.
105. Yushkevich, P. A., Amaral, R. S., Augustinack, J. C., Bender, A. R., Bernstein, J. D., Boccardi, M., et al. (2015). Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol. Neuroimage 111, 526-541. doi: 10.1016/j.neuroimage.2015.01.004.
106. Zhang, B., Ferman, T. J., Boeve, B. F., Smith, G. E., Maroney-Smith, M., Spychalla, A. J., et al. (2015). MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease. J. Neuroimaging 25, 269-274. doi: 10.1111/jon.12138.
107. Zhang, B., Xu, Y., Zhu, B., and Kantarci, K. (2014). The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease. CNS Neurosci. Ther. 20, 3-9. doi: 10.1111/cns.12166.
108. Zhou, J., and Seeley, W. W. (2014). Network dysfunction in Alzheimer's disease and frontotemporal dementia: implications for psychiatry. Biol. Psychiatry 75, 565-573. doi: 10.1016/j.biopsych.2014.01.020.